Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Premature Labor (Tocolysis) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Premature Labor (Tocolysis) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Premature Labor (Tocolysis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
53 pages
Rhabdomyosarcoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rhabdomyosarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Rhabdomyosarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
421 pages
Rhinovirus Infections - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Rhinovirus Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Rhinovirus Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
58 pages
Polycystic Ovarian Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Polycystic Ovarian Syndrome (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Polycystic Ovarian Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
51 pages
Axillary Hyperhidrosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Axillary Hyperhidrosis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Axillary Hyperhidrosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
53 pages
Alcoholic Hepatitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Alcoholic Hepatitis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Alcoholic Hepatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
101 pages
Contact Dermatitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Contact Dermatitis (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Contact Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
43 pages
Hand, Foot and Mouth Disease - Pipeline Review, H1 2020
US$ 2,000.00
... . The Hand, Foot and Mouth Disease (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
46 pages
Retinopathy Of Prematurity - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Retinopathy Of Prematurity (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinopathy Of Prematurity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
62 pages
Arterial Thrombosis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Arterial Thrombosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Arterial Thrombosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
60 pages
Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Neuromyelitis Optica (Devic’s Syndrome) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Neuromyelitis Optica (Devic’s Syndrome) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
147 pages
Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Leber Congenital Amaurosis (LCA) (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Leber Congenital Amaurosis (LCA) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
75 pages
Oligodendroglioma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Oligodendroglioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Oligodendroglioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
156 pages
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Proliferative Diabetic Retinopathy (PDR) (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Proliferative Diabetic Retinopathy (PDR) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
62 pages
Sinusitis - Pipeline Review, H1 2020
US$ 2,000.00
... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Sinusitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
117 pages
Schistosomiasis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Schistosomiasis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Schistosomiasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
42 pages
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020
US$ 2,000.00
... pipeline guide Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Resistant Pseudomonas aeruginosa Infections (Infectious Disease), complete with analysis by stage of development ...
March 2020
58 pages
Uveal Melanoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Uveal Melanoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Uveal Melanoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
312 pages
Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Cancer Anorexia-Cachexia Syndrome (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Cancer Anorexia-Cachexia Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
114 pages
Drug Overdose - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Drug Overdose (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Drug Overdose and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
79 pages
Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H1 2020
US$ 2,000.00
... Ebolavirus Infections (Ebola Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Ebolavirus Infections (Ebola Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
300 pages
Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Epstein-Barr Virus (HHV-4) Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Epstein-Barr Virus (HHV-4) Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
283 pages
Heavy Metal Poisoning - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Heavy Metal Poisoning (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Heavy Metal Poisoning and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
38 pages
Hypopharyngeal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hypopharyngeal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Hypopharyngeal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
336 pages
Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
250 pages
Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenza A Virus, H5N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H5N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
186 pages
Influenzavirus B Infections - Pipeline Review, H1 2020
US$ 2,000.00
... . The Influenzavirus B Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenzavirus B Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
160 pages
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Lassa Fever (Lassa Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Lassa Fever (Lassa Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
62 pages
Malignant Pleural Effusion - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Malignant Pleural Effusion (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Malignant Pleural Effusion and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
49 pages
Marburgvirus Infections (Marburg Hemorrhagic Fever) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Marburgvirus Infections (Marburg Hemorrhagic Fever) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Marburgvirus Infections (Marburg Hemorrhagic Fever) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
102 pages
Fragile X Syndrome - Pipeline Review, H1 2020
US$ 2,000.00
... . The Fragile X Syndrome (Genetic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Fragile X Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
188 pages
Liver Transplant Rejection - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Liver Transplant Rejection (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Liver Transplant Rejection and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
69 pages
Achondroplasia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Achondroplasia (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Achondroplasia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
60 pages
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H1 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 2B - Pipeline Review, H1 2020 SUMMARY 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) pipeline Target constitutes close to 9 molecules. Out of...
March 2020
52 pages
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H1 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H1 2020 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 6 - Pipeline Review, H1 2020'; 5-Hydroxytryptamine Receptor...
March 2020
61 pages
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H1 2020
US$ 3,500.00
5-Hydroxytryptamine Receptor 7 - Pipeline Review, H1 2020 SUMMARY 5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) - 5-HT7 receptor is a member of the GPCR superfamily...
March 2020
74 pages
Actinic (Solar) Keratosis - Pipeline Review, H1 2020
US$ 2,000.00
Actinic (Solar) Keratosis - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Actinic (Solar) Keratosis - Pipeline Review, H1 2020,...
March 2020
66 pages
Aryl Hydrocarbon Receptor - Pipeline Review, H1 2020
US$ 3,500.00
Aryl Hydrocarbon Receptor - Pipeline Review, H1 2020 SUMMARY Aryl Hydrocarbon Receptor (Class E Basic Helix Loop Helix Protein 76 or bHLHe76 or AHR) - Aryl hydrocarbon receptor is a protein encoded...
March 2020
113 pages
C-C Chemokine Receptor Type 4 - Pipeline Review, H1 2020
US$ 3,500.00
C-C Chemokine Receptor Type 4 - Pipeline Review, H1 2020 SUMMARY C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - C-C chemokine receptor type 4 is a protein encoded by the CCR4 gene. CCR4 is...
March 2020
65 pages
Calcitonin Gene Related Peptide - Pipeline Review, H1 2020
US$ 3,500.00
Calcitonin Gene Related Peptide - Pipeline Review, H1 2020 SUMMARY Calcitonin Gene Related Peptide (CGRP) pipeline Target constitutes close to 10 molecules. The latest report Calcitonin Gene Related...
March 2020
81 pages
Heparanase - Pipeline Review, H1 2020
US$ 3,500.00
Heparanase - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Heparanase - Pipeline Review, H1 2020'; Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.1...
March 2020
43 pages
High Mobility Group Protein B1 - Pipeline Review, H1 2020
US$ 3,500.00
High Mobility Group Protein B1 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'High Mobility Group Protein B1 - Pipeline Review, H1 2020'; High Mobility Group Protein...
March 2020
45 pages
Histamine H4 Receptor - Pipeline Review, H1 2020
US$ 3,500.00
Histamine H4 Receptor - Pipeline Review, H1 2020 SUMMARY Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) pipeline Target constitute...
March 2020
52 pages
Huntingtin - Pipeline Review, H1 2020
US$ 3,500.00
Huntingtin - Pipeline Review, H1 2020 SUMMARY Huntingtin (Huntington Disease Protein or HTT) - Huntingtin protein is an encoded by the huntingtin gene, also called the HTT or HD (Huntington disease)...
March 2020
87 pages
